Liquid Biopsy in <i>EGFR</i>-Mutated Advanced NSCLC from T790M to <i>MET</i> Amplification: Clinical Implications and Possibilities in the Resistance Setting

According to the ESMO and ASCO clinical guidelines, the main role of liquid biopsy in <i>EGFR</i>+ advanced NSCLC patients is represented by T790M detection after erlotinib/gefitinib/afatinib progression. However, the general international expert consensus regards osimertinib as the preferred upfron...

ver descrição completa

Detalhes bibliográficos

Principais autores:	Luigi Della Gravara, Ciro Battiloro, Aniello Avellino, Francesca Caputo, Carmine D’Aniello, Danilo Rocco
Formato:	Artigo
Idioma:	Inglês
Publicado em:	MDPI AG 2023-04-01
coleção:	Journal of Molecular Pathology
Assuntos:	NSCLC <i>EGFR</i> <i>MET</i> osimertinib liquid biopsy NGS
Acesso em linha:	https://www.mdpi.com/2673-5261/4/2/9
Tags:	Adicionar Tag Sem tags, seja o primeiro a adicionar uma tag!